These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 3654152

  • 21. Phase II study of mitoxantrone in advanced or metastatic endometrial carcinoma.
    Boadle DJ, Tattersall MH.
    Aust N Z J Obstet Gynaecol; 1987 Nov; 27(4):341-2. PubMed ID: 3453676
    [Abstract] [Full Text] [Related]

  • 22. Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: a Gynecologic Oncology Group study.
    Sutton GP, Blessing JA, McGuire WP, Patton T, Look KY.
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):805-7. PubMed ID: 8456884
    [Abstract] [Full Text] [Related]

  • 23. Phase II trial of mitomycin-C in squamous cell carcinoma of the uterine cervix: a Gynecologic Oncology Group study.
    Thigpen T, Blessing JA, Gallup DG, Maiman M, Soper JT.
    Gynecol Oncol; 1995 Jun; 57(3):376-9. PubMed ID: 7774841
    [Abstract] [Full Text] [Related]

  • 24. Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
    Sutton GP, Blessing JA, Photopulos G, Berman ML, Homesley HD.
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):68-72. PubMed ID: 2539647
    [Abstract] [Full Text] [Related]

  • 25. ICRF-159 (razoxane) in patients with advanced nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
    Homesley HD, Blessing JA, Berman M.
    Am J Clin Oncol; 1986 Aug; 9(4):325-6. PubMed ID: 3751970
    [Abstract] [Full Text] [Related]

  • 26. Phase II study of ifosfamide and mesna in nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group study.
    Sutton GP, Blessing JA, DiSaia PJ, McGuire WP.
    Gynecol Oncol; 1993 Apr; 49(1):48-50. PubMed ID: 8482560
    [Abstract] [Full Text] [Related]

  • 27. Multicenter phase II trial of mitoxantrone in patients with advanced nasopharyngeal carcinoma in Southeast Asia: an Asian-Oceanian Clinical Oncology Association Group study.
    Dugan M, Choy D, Ngai A, Sham J, Choi P, Shiu W, Leung T, Teo P, Prasad U, Lee S.
    J Clin Oncol; 1993 Jan; 11(1):70-6. PubMed ID: 8418245
    [Abstract] [Full Text] [Related]

  • 28. Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Rose PG, Blessing JA, Arseneau J.
    Gynecol Oncol; 1996 Jul; 62(1):100-2. PubMed ID: 8690279
    [Abstract] [Full Text] [Related]

  • 29. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
    Mannel RS, Blessing JA, Boike G.
    Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
    [Abstract] [Full Text] [Related]

  • 30. Phase II trial of 5-fluorouracil and high-dose leucovorin in recurrent adenocarcinoma of the cervix: a Gynecologic Oncology Group study.
    Look KY, Blessing JA, Valea FA, McGehee R, Manetta A, Webster KD, Andersen WA.
    Gynecol Oncol; 1997 Dec; 67(3):255-8. PubMed ID: 9441772
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Muggia FM, Blessing JA, Waggoner S, Berek JS, Monk BJ, Sorosky J, Pearl ML.
    Gynecol Oncol; 2005 Jan; 96(1):108-11. PubMed ID: 15589588
    [Abstract] [Full Text] [Related]

  • 32. Aminothiadiazole (NSC 4728) in patients with advanced nonsquamous carcinoma of the cervix. A phase II study of the Gynecologic Oncology Group.
    Asbury RF, Blessing JA, DiSaia PJ, Malfetano J.
    Am J Clin Oncol; 1989 Oct; 12(5):375-7. PubMed ID: 2801597
    [Abstract] [Full Text] [Related]

  • 33. Phase II trial of menogaril in patients with squamous carcinoma of the cervix: a Gynecologic Oncology Group study.
    Sutton GP, Blessing JA, Barrett RJ, Gallup DG.
    Gynecol Oncol; 1994 Feb; 52(2):229-31. PubMed ID: 8314144
    [Abstract] [Full Text] [Related]

  • 34. PALA (NSC-224131) in advanced carcinoma of the cervix. A phase II study of the Gynecologic Oncology Group.
    Muss HB, Bundy B, DiSaia PJ, Stehman FB, Beecham J.
    Am J Clin Oncol; 1984 Dec; 7(6):741-4. PubMed ID: 6528869
    [Abstract] [Full Text] [Related]

  • 35. A phase II evaluation of mitolactol in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Stehman FB, Blessing JA, McGehee R, Barrett RJ.
    J Clin Oncol; 1989 Dec; 7(12):1892-5. PubMed ID: 2685182
    [Abstract] [Full Text] [Related]

  • 36. Mitoxantrone in advanced cervical carcinoma: a phase II study in patients not previously treated with chemotherapy.
    Hørding U, Rose C, Jakobsen K, Dirksen H.
    Cancer Treat Rep; 1986 Oct; 70(10):1239-40. PubMed ID: 3756944
    [No Abstract] [Full Text] [Related]

  • 37. Phase II trial of piperazinedione (NCS 135758) in the treatment of advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
    Thigpen JT, Blessing J, Homesley HD, Adcock LL.
    Am J Clin Oncol; 1983 Aug; 6(4):423-6. PubMed ID: 6688150
    [Abstract] [Full Text] [Related]

  • 38. Phase II trial of mitoxantrone in head and neck carcinoma.
    Sridhar KS, Hussein AM, Benedetto P, Waldman SM, Feun LG, Savaraj N, Richman SP, Ardalan B, Desai P.
    Am J Clin Oncol; 1991 Aug; 14(4):298-304. PubMed ID: 1650529
    [Abstract] [Full Text] [Related]

  • 39. 5-fluorouracil and low-dose leucovorin in the treatment of recurrent squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
    Look KY, Blessing JA, Muss HB, Partridge EE, Malfetano JH.
    Am J Clin Oncol; 1992 Dec; 15(6):497-9. PubMed ID: 1449112
    [Abstract] [Full Text] [Related]

  • 40. A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study.
    Look KY, Blessing JA, Levenback C, Kohler M, Chafe W, Roman LD.
    Gynecol Oncol; 1998 Sep; 70(3):334-8. PubMed ID: 9790784
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.